If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Well, that's a load of crap isn't it!
A 27 mi profit from what? Does not even reflect business model. This is why its all a joke. They dont need to have a blue chip drug, they need to know how to license successfully and unfortunately the company does not and that will be its downfall
Normally Ahfam is great for this information, but with him no longer on this board good to see you have uncovered this. Anyone any ideas where Ahfam went to or has he moved on an channelling all his energy into another share?
Where do you infer that SRA737 is being considered by pharma for combo trialling?
Its a dead duck . it has been stated that combo trialling is the only way to resurrect, nowhere has it been mentioned that pharma are considering it?
SRA737 was well tolerated at doses that achieved preclinically relevant drug concentrations but single agent activity did not warrant further development as monotherapy. Given its mechanism of action resulting in abrogating DNA damage repair, further clinical development of SRA737 should be as combination therapy.
April 2023 so over 6 months ago and since nothing
I still do not understand why the positivity about SRA 737 given it journey of licensing, then Sierra not progressing, then GSK happy to return and since then , nothing?
not being negative, but i fail to see why so many put so much value to it. It has had a go and its a non starter or am i missing something?
Some people love to accuse people of an agenda on here, in reality i feel that there is only person who is quite overzealous who likes to ramp it. you know who you are. His timelines and predictions are so out of whack with what is actually happening. Somone suggested no support at these prices. I could not agree more. This will undoubtably test the 50's this week and possibly the 40's next few weeks. I'm staying put for now though as i have come too far to risk trading.
The market determines the price Ahfam not you. I would say price is suffering because it's a slow process with not much communication but more importantly SRA737 not even being talked about. The price is where it is for a reason. I expect it will go to 50p by year end but that is not a problem. Don't forget , there is an opportunity cost to owning SAR shares right now as we are not earning anywhere else so there will be investors taking their money out
I hold 23,000 shares as i have consistently said.
Parrot no i do not know, but there are some very knowledgeable people on this board so i asked the question. I suppose fundamentally noon is really buying and noone is really selling so mm move it a bit just to give a nudge for activity, but i would have expected as we the trails are further down the track each day a little increase in price would happen but we are not really seeing it
Not the boom boom rns that some predicted but pretty healthy. Qtr 3 this year, so by end of Sept 23 more news by the latest. Funding in place which has not disrupted price too much so that's ok. Also highlights that are not in the driving seat for SRA 737 so to me that can be taken off the table and people on this board need to be unscrupulously pushing it as there is nothing on the horizon. So, i think should calm down a bit, the rns did not deserve 88 postings in 1 day. Let's see what Sept/Oct gives up.